Gál E M, Whitacre D H
Neurochem Res. 1981 Mar;6(3):233-41. doi: 10.1007/BF00964039.
Repeated intraventricular injections of 2,4-diamino-6-hydroxypyrimidine (DAO-Pyr), inhibitor of D-erythro-q-dihydroneopterin triphosphate synthetase, inhibited q-BH2 synthesis from GTP, markedly increased accumulation of 2-amino-4-hydroxy-5 (or -6)-formamido-6-triphosphoribosylaminopyrimidine (FPyd-P3) and brought about a 60% decrease in the in vivo of reduced biopterin (BH2 and BH4) pool in the brain. Nevertheless, there was no effect on the rate of hydroxylation of L-tryptophan or on the 5-hydroxytryptamine level in rat brain. These data emphasized the significance of the rate of hydrogen transfer and the limitation of the concept of "unsaturation" (i.e., the absolute amount of the carrier pterin molecule) for the synthesis of neurotransmitters in vivo.
反复脑室内注射2,4-二氨基-6-羟基嘧啶(DAO-Pyr),即D-赤藓糖型-q-二氢新蝶呤三磷酸合成酶的抑制剂,可抑制由GTP合成q-BH2,显著增加2-氨基-4-羟基-5(或-6)-甲酰胺基-6-三磷酸核糖氨基嘧啶(FPyd-P3)的蓄积,并使脑内还原型生物蝶呤(BH2和BH4)池的体内含量降低60%。然而,对大鼠脑内L-色氨酸的羟化速率或5-羟色胺水平并无影响。这些数据强调了氢转移速率的重要性以及“不饱和性”概念(即载体蝶呤分子的绝对量)在体内神经递质合成方面的局限性。